全文获取类型
收费全文 | 3989篇 |
免费 | 247篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 137篇 |
妇产科学 | 157篇 |
基础医学 | 381篇 |
口腔科学 | 41篇 |
临床医学 | 819篇 |
内科学 | 797篇 |
皮肤病学 | 40篇 |
神经病学 | 273篇 |
特种医学 | 45篇 |
外科学 | 349篇 |
综合类 | 33篇 |
一般理论 | 6篇 |
预防医学 | 632篇 |
眼科学 | 30篇 |
药学 | 232篇 |
中国医学 | 7篇 |
肿瘤学 | 246篇 |
出版年
2023年 | 27篇 |
2022年 | 42篇 |
2021年 | 96篇 |
2020年 | 51篇 |
2019年 | 82篇 |
2018年 | 101篇 |
2017年 | 82篇 |
2016年 | 95篇 |
2015年 | 103篇 |
2014年 | 120篇 |
2013年 | 217篇 |
2012年 | 302篇 |
2011年 | 310篇 |
2010年 | 177篇 |
2009年 | 149篇 |
2008年 | 270篇 |
2007年 | 342篇 |
2006年 | 352篇 |
2005年 | 284篇 |
2004年 | 243篇 |
2003年 | 215篇 |
2002年 | 207篇 |
2001年 | 44篇 |
2000年 | 31篇 |
1999年 | 34篇 |
1998年 | 28篇 |
1997年 | 19篇 |
1996年 | 18篇 |
1995年 | 14篇 |
1994年 | 13篇 |
1993年 | 11篇 |
1992年 | 10篇 |
1991年 | 20篇 |
1990年 | 11篇 |
1989年 | 12篇 |
1988年 | 17篇 |
1987年 | 9篇 |
1986年 | 6篇 |
1985年 | 8篇 |
1984年 | 5篇 |
1983年 | 3篇 |
1982年 | 5篇 |
1981年 | 5篇 |
1980年 | 6篇 |
1979年 | 8篇 |
1974年 | 3篇 |
1973年 | 4篇 |
1972年 | 3篇 |
1971年 | 3篇 |
1965年 | 3篇 |
排序方式: 共有4243条查询结果,搜索用时 9 毫秒
31.
32.
33.
34.
Bamer Alyssa M. McMullen Kara Wolf Steven E. Stewart Barclay T. Kazis Lewis Rencken Camerin A. Amtmann Dagmar 《Quality of life research》2021,30(7):2071-2080
Quality of Life Research - To examine agreement between pediatric burn survivor self- and caregiver proxy-report on multiple PROMIS domains and examine factors associated with differences between... 相似文献
35.
Issa Loutfi Patricia M. Chisholm Debbie Bevan John P. Lavender 《European journal of nuclear medicine and molecular imaging》1990,16(2):69-76
An indium 111-labelled mouse anti-rat T cell monoclonal antibody, MRC OX-19, was injected intravenously into rats to establish the usefulness of radiolabelled anti-lymphocyte antibodies in imaging lymphoid tissues. Antibody binding in vivo, measured by immunofluorescence analysis of cell suspensions made from lymphoid tissues, was detectable on lymphocytes in blood, spleen and lymph nodes. The extent of binding was time and antibody-dose dependent. Doses of antibody above 80 g/kg body weight resulted in modulation, i.e. loss of CD 5 (T 1) molecules from the cell surface, although the cells remained in the circulation. Modulation was demonstrable within 2 h and for at least 24 h after a single injection of antibody. Intravenous injection of111In-MRC OX-19 resulted in levels of in vivo binding comparable with those seen with unlabelled antibody. Scintillation imaging showed early splenic localisation persisting over 48h, a more gradual localisation in the lymph nodes seen clearly at 24 h and a steady background. Comparison of the in vivo distribution of labelled antibody and111In-tropolone-labelled lymphocytes showed that both could be used for external imaging of lymphocytes by scintillation camera. 相似文献
36.
James W. Paxton Debbie Young Sean M. H. Evans Iain G. C. Robertson Philip Kestell 《Cancer chemotherapy and pharmacology》1993,32(4):320-322
N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (AC) is an experimental antitumour agent that is being considered for phase I trials. After i.p. administration of 150 mg/kg [3H]-AC to tumour-bearing mice, AC was absorbed rapidly into the plasma and tissues such as the heart, liver, kidney and brain but more slowly into the s.c. tumour. The maximal AC concentration (86±36 mol/kg) in the tumour occurred at 35–60 min and was 3-fold the maximal plasma concentration, which occurred at 15 min. Although higher maximal concentrations were observed in other tissues, these concentrations fell rapidly in parallel with plasma concentrations. In contrast, AC concentrations in the tumour remained elevated, thet1/2 value (16.3 h) and mean residence time (MRT, 9.5 h) being prolonged in comparison with those in the plasma and other tissues (t1/2 range, 1.0–2.9 h; MRT, 1.2–1.4 h). AC concentrations were not detectable by our high-performance liquid chromatographic (HPLC) method (limit of detection, 0.02 mol/l) in the plasma or other tissues at 24 or 48 h after administration but were measurable in the tumour (1.6±0.8 and 0.6±0.3 mol/kg, respectively). Radioactivity concentrations in the plasma, tissues and tumour were very variable but were greater than the corresponding levels of unchanged parent AC. By 24 h, radioactivity concentrations in the plasma, tissues and tumour had fallen to similar levels with prolonged elimination profiles. Thus, the exposure of the s.c. implanted tumour to a threshold AC concentration for a prolonged time (>24 h) may partly explain the greater efficacy of AC against this tumour, whereas the shorter period of exposure of blood and other tissues may explain its low haematological toxicity. 相似文献
37.
Makaula NA Marasas WF Badenhorst CJ Bradshaw D Swanevelder S 《African journal of health sciences》1995,2(3):333-337
New data regarding the incidence of oesophageal and other cancers during the period 1985-1990 are reported for all clinics and hospitals in four selected districts of Transkei, Southern Africa i.e Kentani, Butterworth, Lusikisiki and Bizana. Active and passive methods were used to obtain the hospital-based cancer registry data. The mean annual number of cancer cases recorded for the period 1985-1990 was 292. Age-standardized incidence rates (ASIIR, African Standard) for all recorded cancers were 81.4 and 52.6/100,000 for males and females, respectively. Histopathogical examination of 52.6% of recorded tumours revealed that 67.3% were squamous carcinomas, 21.7% adenocarcinomas and the remainder non-epithelial neoplasms. Cancer of the oesophagus (EC) was the most frequently recorded cancer and accounted for 46.5% of the cases with mean ASIR of 46.7 and 19.2/100,000 for males and females, respectively. The male/female ratio was 2:4:1. The highest mean ASIR per annum for OC in males (55.6/100,000) occurred in Kentani and in females (22.3/100,000) in Lusikisiki, whereas the lowest rates in both sexes (37.0 and 11.7/100,000 respectively) occurred in Bizana. Comparison of the OC rates in the four districts of Transkei during 1985-1990 with previously reported trends, confirms a consistently high rate in the south-western district of Kentani during the past 35 years and progressively increasing rates in the north-eastern districts of Bizana and Lusikisiki. These results have profound implications for further epidemiological and aetiological studies on OC in Transkei, but need to be corroborated by data from other sources such as statistics on histologically diagnosed cancer in Transkei by district in the South African National Cancer Registry. The second most frequently recorded cancer among males was liver cancer with a mean annual ASIR of 6.0/100,0000 and a male: female ratio of 3:1. The most frequently recorded cancer with a mean annual AISR of 20.9/100,000 followed by OC (19.2/100,000) and breast cancer (5.8/100,000). 相似文献
38.
39.
Analysis of client characteristics that may affect early discontinuation of the TCu-380A IUD 总被引:3,自引:0,他引:3
The purpose of this study was to analyze the reasons for early discontinuation of the TCu-380A IUD in women participating in a large multicenter trial. The study relates specific characteristics of the women at the time of TCu-380A insertion with specific 1-year reasons for discontinuation. A secondary analysis was performed on data obtained from 2748 women from sites in Africa, Asia, and Latin America. By the end of the year, 321 discontinuations were observed. The gross cumulative 12-month life table rates of reasons for discontinuation were 13.3 for all reasons and 3.1, 4.5, and 4.3 for expulsion, removals for bleeding/pain, and personal reasons, respectively. Study site, age, and religion had a significant effect on early discontinuation. Women who had IUD insertions in the African centers had significantly higher expulsion rates than women from other centers. Women < 20 years old had significantly higher expulsion rates than older women. Muslim women had significantly higher rates of removal for bleeding and pain than women of other religions. This information may guide the counseling and follow-up process of women with such characteristics and result in a more satisfactory use and improved continuation rates of the TCu 380A. 相似文献
40.